Moving liquid biopsies to the Front-line of lung cancer treatment decisions
Author:
Publisher
Elsevier BV
Reference18 articles.
1. Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update;Blons;J Thorac Dis,2019
2. Prospective clinical validation of the InVisionFirst-lung circulating tumor DNA assay for molecular profiling of patients with advanced nonsquamous non–small-cell lung cancer;Pritchett;JCO Precis Oncol,2019
3. Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy;Garcia-Pardo;Ther Adv Med Oncol,2022
4. Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non–small cell lung cancer;Leighl;Clin Cancer Res,2019
5. Clinical outcomes for plasma-based comprehensive genomic profiling versus standard-of-care tissue testing in advanced non–small cell lung cancer;Page;Clin Lung Cancer,2022
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liquid biopsy applications in oral oncology: Clinical utility and future directions;Oral Oncology Reports;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3